Clinical Assessment of the BreathAlert Device in Monitoring Apneic Episodes

Recruiting now

Conditions studied: Apnea Infant

In brief

A team of researchers at Rice University in partnership with clinicians at Queen Elizabeth Central Hospital created BreathAlert, a low cost battery-powered monitor that detects and corrects apnea. This study evaluates the ability of BreathAlert to detect respiration and apneic episodes in infants. Data from BreathAlert and vital signs monitors is collected. The performance of BreathAlert in respiration and apnea detection is compared with traditional vital sign monitoring which may include temperature, heart rate, EKG, respiratory rate, SPO2 and impedance pneumography.

Key facts

Study ID

NCT07704320

Run by

William Marsh Rice University

People needed

60

Starts

2017-03-11

Expected to finish

2028-06-01

Last updated by the study team

2026-07-15

Who can join

Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants will be identified using the eligibility criteria stipulated below.
• The patient is currently being treated at QECH in the neonatal or pediatric ward.
• The patient is deemed to be at risk for apnea or in need of respiratory rate monitoring.
• A BreathAlert device is available for use while the patient is at risk for apnea.
• The patient's caregiver has provided informed consent for their child to participate.

Where it is running

• Queen Elizabeth Central Hospital — Blantyre, Malawi (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.